Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Alvotech And Prestige Strike Biosimilar Manufacturing Deal

27 Aug 2019

• By Dave Wallace

Handshake — Alvotech And Prestige Have Agreed A Manufacturing Deal • Source: Shutterstock

Related Content

Products Roundup - 19 December 2018: European Commission Approves Mylan/Biocon’s Ogivri Biosimilar, Amgen Files Infliximab With The FDA And Hikma Debuts Dalfampridine

19 Dec 2018

Cipla And Alvotech Prime Emerging Markets Push With Adalimumab Deal

30 Jul 2019

Alvotech Moves Ahead On Higher-Concentration Humira Rival

15 Jul 2019

Mundipharma Strikes Deal For Prestige's Trastuzumab

02 Jul 2019

Pharmapark Will Market Prestige's Trastuzumab In Russia

08 Jul 2019

Sandoz Biopharma Head Levick To Become CEO Of Alvotech

10 May 2019

Biosimilar deals forge a trio of partnerships

06 Jul 2018

Related Companies

Alvotech

Mundipharma International Limited

Cipla Limited

Alvogen, Inc.

Additional Topics

Deals Manufacturing Biosimilars BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.